Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (171-180 of 287) with videos related to

Pageof 29
Sort By:
Oncology|January 1, 1994
Prognostic factors of the clinical response to subcutaneous immunotherapy with interleukin-2 alone in patients with metastatic renal cell carcinomaP Lissoni, S Barni, A Ardizzoia, et al.
The European Journal of Surgery = Acta Chirurgica|January 1, 1993
Effects of a preoperative course of interleukin-2 on surgical and immunobiological variables in patients with colorectal cancer: a phase 2 studyF Brivio, P Lissoni, S Barni, et al.
Tumori|June 30, 1988
Melatonin increase as predictor for tumor objective response to chemotherapy in advanced cancer patientsP Lissoni, G Tancini, S Barni, et al.
The International Journal of Biological Markers|October 1, 1992
Effects of interleukin-2 immunotherapy on soluble lymphocyte markers in cancer patientsP Lissoni, F Rovelli, E Tisi, et al.
Tumori|June 30, 1994
Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactinS Barni, P Lissoni, F Brivio, et al.
The International Journal of Biological Markers|July 17, 2008
Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastasesP Lissoni, S Meregalli, S Curreri, et al.
Tumori|August 31, 1986
Prolactin response to thyrotropin-releasing hormone in early and advanced human breast cancerS Barni, P Lissoni, G Tancini, et al.
Oncology|November 1, 1995
Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretionP Lissoni, S Barni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Melatonin as a new possible anti-inflammatory agentP Lissoni, F Rovelli, S Meregalli, et al.
Anticancer Research|May 1, 1990
Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancerP Lissoni, S Barni, C Archili, et al.
Pageof 29

Showing results (171-180 of 287) with videos related to

Sort By:
Pageof 29
Oncology|January 1, 1994
Prognostic factors of the clinical response to subcutaneous immunotherapy with interleukin-2 alone in patients with metastatic renal cell carcinomaP Lissoni, S Barni, A Ardizzoia, et al.
The European Journal of Surgery = Acta Chirurgica|January 1, 1993
Effects of a preoperative course of interleukin-2 on surgical and immunobiological variables in patients with colorectal cancer: a phase 2 studyF Brivio, P Lissoni, S Barni, et al.
Tumori|June 30, 1988
Melatonin increase as predictor for tumor objective response to chemotherapy in advanced cancer patientsP Lissoni, G Tancini, S Barni, et al.
The International Journal of Biological Markers|October 1, 1992
Effects of interleukin-2 immunotherapy on soluble lymphocyte markers in cancer patientsP Lissoni, F Rovelli, E Tisi, et al.
Tumori|June 30, 1994
Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactinS Barni, P Lissoni, F Brivio, et al.
The International Journal of Biological Markers|July 17, 2008
Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastasesP Lissoni, S Meregalli, S Curreri, et al.
Tumori|August 31, 1986
Prolactin response to thyrotropin-releasing hormone in early and advanced human breast cancerS Barni, P Lissoni, G Tancini, et al.
Oncology|November 1, 1995
Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretionP Lissoni, S Barni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Melatonin as a new possible anti-inflammatory agentP Lissoni, F Rovelli, S Meregalli, et al.
Anticancer Research|May 1, 1990
Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancerP Lissoni, S Barni, C Archili, et al.
Pageof 29